rawfin.tv
Aprea Therapeutics Files for Resale of 5.5 Million Shares by Selling Stockholders
MarketsstocksAI Generated

Aprea Therapeutics Files for Resale of 5.5 Million Shares by Selling Stockholders

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Aprea Therapeutics (APRE) has filed an SEC notice for the resale of up to 5.5 million shares by its existing stockholders. This filing indicates potential selling pressure on the company's stock.

APREShare ResaleSEC FilingStock OfferingBiotech

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks